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Trophic Influence of the Sympathetic Nervous System on the Rat Portal Vein
OCTAVIO APRIGLIANO AND KENT HERMSMEYER SUMMARY Adrenergic denervation of the rat portal vein was produced in vivo by the sympatholytic agent 6hydroxydopamine (6-OHDA). Treatment of rats with 6-OHDA decreased the responses of the portal veins to nerve stimulation, reduced 3 H-norepinephrine (NE) uptake, and decreased catecholamine fluorescence, indicating that partial adrenergic denervation was achieved. The main findings of this study indicate that the in vivo denervation produced: (1) a (time-dependent) increase in sensitivity of the veins to NE, which was not of prejunctional origin, (2) an increase in sensitivity to BaCI 2 , and (3) a partial depolarization of the myovascular cells. The results suggest that the in vivo denervation of the portal veins by 6-OHDA produces a postjunctional alteration, which may be due to the removal of a trophic influence of the sympathetic nervous system. It is proposed that the partial depolarization and associated ionic changes may be components of the mechanism. These results provide the first direct evidence that membrane excitability changes are involved in trophic nerve-muscle interactions in blood vessels.
MOTOR innervation can control and modulate in many ways the homeostasis of effector cells (for reviews see Thesleff, 1 Guth, 2 Gutmann, 3 and Fleming et al. 4 ). These interrelationships between nerve and effector cells have been generally classified as trophic phenomena. The trophic influences of nerve on muscle may be defined as long term interactions affecting or regulating the muscle cells in addition to the more immediate phenomenon of junctional transmission. The common approach to the study of neurotrophic influences is to interrupt the normal nerve-muscle contact by surgical or functional denervation and to observe the changes in some muscle cell function during and after denervation and the reversal of these changes on reestablishment of normal innervation. Thus, it was shown that denervation induces changes in the metabolic profile of striated 5 and nonstriated muscle cells. 6 Innervation also exerts control over the muscle's speed of contraction, 7 calcium uptake and release mechanisms, 8 " 10 and membrane excitability."" 15 A trophic phenomenon that has received considerable attention is the control exerted by innervation on the chemical sensitivity of muscle cells. 1 ' 4 When the effector cell is deprived of its motor innervation it becomes more sensitive to the neurotransmitter and to other agents. 16 Considerable advances have been made in the study of the mechanisms underlying denervation supersensitivity in skeletal muscles (e.g., Thesleff 1 ). On the other hand, data on denervation supersensitivity in smooth muscles are still scarce in many areas and there is no systematic study of neurotrophic influences on autonomic effectors. In adrenergically innervated structures denervation supersensitivity has at least two components. 17 One is called prejunctional and is due to impairment of the neuronal uptake mechanism. Loss of this mechanism causes an apparent increase in the sensitivity of the effector organ to amines which are taken up by the nerve terminals. The second type of supersensitivity has been named postjunctional; this implies a change in the effector cells. It is a timedependent and nonspecific phenomenon that develops not only with respect to NE but also to other drugs and ions. Postjunctional supersensitivity has been proposed to be part of a mechanism of adaptation that is triggered whenever the effector cells are deprived of their normal neural input. 4 The purpose of this study was to assess the development of postjunctional supersensitivity and other changes resulting from the removal of a normal trophic influence of the sympathetic nervous system on portal vein. The importance of this study is that (1) there is a limited amount of information on denervation supersensitivity in blood vessels, and (2) certain diseases of the vascular system may be related, at least during some stage, to alterations of the sympathetic nervous system.
Methods
Portal mesenteric veins from male (200-250 g) Wistar albino rats anesthetized with sodium pentobarbital (30 mg/kg, ip) were exposed, freed of surrounding tissue, immediately removed from the animals, and placed in physiological electrolyte solution.
RECORDINGS OF MECHANICAL ACTIVITY
Portal veins were slit open and mounted as 15-mm-Iong strips in a muscle chamber. The preparations were continuously superfused without recirculation with physiological electrolyte solution (composition in IDM: NaCI, 137; MgCl 2 , 1.0; NaHCO 3 , 11.9; KC1, 2.69, NaH 2 PO 4 , 1.06; CaNa 2 ethylenediaminetetraacetic acid (EDTA), 0.03; CaCl 2 , 1.8; and glucose 7.8). The solution was maintained at 37°C and gassed with 95% O 2 , 5% CO 2 , to give a pH of 7.2. Recordings of isometric tension were made with Grass FT 03 transducers connected to a Grass polygraph. The initial tension applied to the portal vein preparations was 750 dyn/ 4 x 10" 3 cm 2 .
Data from these experiments were recorded simultaneously on the Grass polygraph and on an FM tape recorder to be analyzed later by a digital PDP12 computer in the following manner. Contractile responses were measured as the time integral of the tension developed over a 2.5minute period that began with drug injection or during a control preinjection period. Baseline was determined by the computer program 1 second before each integration began to eliminate errors introduced by drift. The spontaneous activity exhibited by the portal veins during control periods had a variable force integral. For this reason the area under the curve for each preinjection period was determined and subtracted from that force integral found during exposure to drug.
NOREPINEPHRINE CONCENTRATION-RESPONSE CURVES
Norepinephrine (NE) was applied in increasing concentrations ranging from 0.01 Mg/ml to 10 ptg/ml with an interval of at least 10 minutes between doses. The period of drug exposure at each concentration was 2.5 minutes (the same as the recording period) in all cases. The concentration of drug necessary to produce 50% of the maximal response (EC 50 ) was obtained for each individual concentration-response curve using a computer program for sigmoid curve fit by least squares for the logistic transformation of the data (see Finney 18 for discussion of the relative merits of logit vs. probit transformation). The results are expressed as geometrical mean EC 50 values with the confidence intervals, based on the observed normal distribution of log concentration. 19 To test for loss of ability of nerve endings to release NE, the preparations were field-stimulated with a Grass stimulator connected to a pair of platinum ring electrodes placed at opposite ends of the vessel strips. Rectangular pulses of 0.3 msec duration and a frequency of 10 Hz were applied for periods of 15 seconds. With such stimulation parameters only the nerves in the vessel wall were stimulated 20 by current densities just great enough to produce maximal contraction of untreated vessels.
INCUBATIONS WITH 3 H-NOREPINEPHRINE
Portal vein preparations were incubated for 60 minutes in 1 ml of physiological electrolyte solution containing dl-NE-7-3 H, 9.8 Ci/mmol (New England Nuclear) and ascorbic acid (20 /xg/ml) at 37°C. The incubations were performed after treatment with 6-OHDA or the vehicle. Experiments also were conducted in the presence of cocaine (10" 5 M). 3 H-NE (15 ng) was added to the portal vein preparations to give a concentration of 9 x 10~8 M. For assay of 3 H-catecholamines the vessels were washed three times for periods of 2 minutes in fresh physiological solutions, homogenized in groups of two in ice-cold 0.4 N perchloric acid, and 3 H-catecholamines were isolated on alumina columns 21 and assayed by liquid scintillation counting. 3 H-catecholamine recovery was 74%.
6-OHDA TREATMENT
The treatment schedule with 6-OHDA consisted of two intraperitoneal injections 3 hours apart of 50 mg/kg each. VOL. 41, No. 2, AUGUST 1977 The drug was dissolved in 0.6 ml of 0.9% NaCl acidified with hydrochloric acid or glutathione (pH 4.7). Control rats received equivalent volumes of the vehicle. In other experiments, administration of the same treatment schedule 5 days later or administration of a single dose of 6-OHDA of up to 200 mg/kg produced no greater magnitude or duration of denervation.
FLUORESCENCE HISTOCHEMISTRY
Vessels were removed quickly from the rats at specified times after 6-OHDA or vehicle treatment, frozen in liquid propane cooled with liquid nitrogen, and processed according to a modification of the method of Falck et al. 22 as recently described by Bjorklund et al. 23 All preparations were examined with a Leitz Orthoplan fluorescence microscope using incident light excitation at 490 nm.
INTRACELLULAR RECORDINGS
Glass micropipette electrodes (20-50 Mfl) filled with 3 M KG and suspended from a 25-/u.m Ag wire were used to record resting membrane potential. Two methods were used to mount the tissues: in some experiments the portal veins were slit open longitudinally to form a sheet; in others the vessels were kept intact and subsequently cannulated with a conical trough-shaped device, whose size was optimal to maintain the circumference of the vein approximately equal to that found in situ. This latter procedure yielded more consistent impalements. Care was taken to avoid excessive stretch of the tissues at all times. Next, the preparations were pinned in 2-ml muscle chambers made of silicone rubber and continuously superfused, without recirculation, at a rate of 3 ml/min with the physiological electrolyte solution previously described. The superfusate was bubbled continuously with 95% O 2 , 5% CO 2 at 36°C. The recording microelectrode and the bathing solution were connected to a W-P Instruments M701 high input impedance amplifier (>10" fl) with provisions for current injection and capacitance neutralization. The reference electrode was an Ag:AgCl half-cell. The electrical recordings were displayed simultaneously on a Tektronix R5031 storage oscilloscope connected to the preamplifier output. Impalements were considered acceptable only if the following criteria were met: (1) cell impalement was indicated by a sharp voltage drop; (2) cell input resistance (single microelectrode) was between 4 and 20 Mfl; (3) reference potential (±2 mV) and electrode resistance (±1 Mfl), compared before and after the impalement, were constant.
Cell input resistance was taken as the voltage produced by injection of a known current through the microelectrode (A Em/I,,). The electrode resistance was always measured before making any measurements. All experiments were performed with both control and treated vessels in the muscle chamber at the same time and using a matchedelectrode procedure (to control variability due to electrode characteristics, the same electrode alternated between control and treated vessels to produce the same number of measurements). On some occasions, when the preparations presented spontaneous spikes, data were collected exclusively from spiking cells. All recordings were made after a period of equilibration of at least 45 minutes.
DRUGS
The following drugs were used: /-arterenol bitartrate (7-NE, Sigma), 6-hydroxydopamine HBr (Sigma), acetylcholine chloride (Sigma), cocaine HC1 (University of Iowa Pharmacy Services), KG and BaCl 2 (Fischer, reagent grade), phentolamine HCI (Ciba), and glutathione (GSH) (Calbiochem). The drugs/-NE, 6-OHDA, and GSH were dissolved, while stock solutions of phentolamine, cocaine, acetylcholine, KG, and BaCl 2 were diluted in physiological electrolyte solution immediately before use.
Results

CATECHOLAMINE DEPLETION AFTER CHEMICAL SYMPATHECTOMY
Fluorescence histochemistry studies were performed on veins frozen upon excision from rats treated 1,3, and 5 days previously with either 6-OHDA or the vehicle. In these experiments sections taken from at least two control and two treated veins for each day of treatment were examined. Fluorescence micrographs of veins from vehicle-treated rats showed characteristic adrenergic innervation similar to that previously described 24 and exemplified in Figure 1A .
One day after 6-OHDA administration, catecholamines were depleted in all sections examined ( Fig. IB) . Most sections examined 3 days after 6-OHDA treatment also revealed catecholamine depletion, although some micrographs showed specific catecholamine fluorescence at the adventitiomedial border of the vein and between the longitudinal and circular muscle layers. Examination of veins taken from rats treated 5 days previously showed that in some parts of the vessels there was depletion of catecholamines and in others there were signs of adrenergic innervation between the muscle layers as shown in Figure 1C . Arterioles associated with the 5-day veins displayed the typical fluorescence of adrenergic innervation (Fig. ID) , a feature observed in controls but not observed 1 and 3 days after 6-OHDA administration.
RESPONSES TO FIELD STIMULATION
The contractile responses of the veins to nerve stimulation were obtained by measuring the time integral of tension during field stimulation for 15 seconds. Responses of control vessels were extremely reproducible; the same stimulation parameters always elicited tension integrals within a limited range, as indicated in Figure 2 . This graph also indicates that the contractile responses were abolished completely 1 day after 6-OHDA treatment but gradually reappeared at 2 and 3 days. Five days after chemical sympathectomy with 6-OHDA the responses to nerve stimulation were approximately 40% of controls.
H-NOREPINEPHRINE UPTAKE
Portal veins were incubated for 1 hour with 3 H-NE 1,3, and 5 days after chemical sympathectomy with 6-OHDA ( Fig. 3 ). Preparations treated with cocaine (10~5 M) were exposed to this drug 15 minutes before 3 H-NE incubation and maintained in a cocaine-containing solution throughout the entire incubation period. One day after 6-OHDA treatment, NE uptake was reduced to approximately 21 % of control; at 3 days it was 33% of controls and 5 days after 6-OHDA it was approximately 39% of controls. The decrease in NE uptake caused by 6-OHDA treatment was comparable to that caused by cocaine.
SUPERSENSITIVITY TO NE AFTER ADRENERGIC DENERVATION
Concentration-response (C-R) curves to NE were obtained 1, 2, 3, and 5 days after 6-OHDA administration (Fig. 4) . The EC 50 at each point is plotted as the geometrical mean EC 50 , with the respective confidence intervals based on individual C-R curves obtained in each group of experiments. The mean EC 50 for NE obtained after the in vitro treatment with 6-OHDA 20 is indicated for purposes of comparison. This value indicates the increase in sensitivity to NE caused by the complete impairment of the neuronal uptake mechanism (prejunctional supersensitivity).
One day after 6-OHDA administration, the EC 50 for NE fell from 0.14 /xg/ml to 0.06 Mg/ml; this represents a ; (30, 50) 2.3-fold increase in sensitivity. At 2 days the EC 50 tended to increase slightly but this point is not significantly different from that obtained at day 1. At 3 days the EC 50 showed an additional fall; this represents a 3.5-fold increase in sensitivity from control and is significantly greater than the values obtained after in vitro treatment with 6-OHDA. At 5 days the EC 50 was significantly lower than control but higher than that obtained in the 3-day experiments. A complete picture of the C-R curves obtained at the point of maximum change in sensitivity to NE is presented in Figure 5 no significant difference in the magnitude of the maximum tension integral of control and denervated veins. The responses of the portal veins to low concentrations of NE (0.01 £ig/ml) also were increased at 1, 2, and 5 days after 6-OHDA treatment. This concentration, which usually causes responses at about the 11% level in control preparations, caused significantly higher contractions (20-25% level) of denervated portal veins.
SUPERSENSmVITY TO BARIUM CHLORIDE
BaCl 2 induced maximal contractions which were similar to those obtained with maximal doses of NE. In most cases BaCl 2 , 10 HIM, induced an immediate increase in tension interspersed with some spontaneous fluctuations that eventually fused into a sustained contraction. This contraction subsided a few minutes after washing BaCl 2 out of the preparations. Low concentrations of BaCl 2 always induced an increase in spontaneous activity of the veins. Concentration-response curves for BaCl 2 were obtained in the presence of phentolamine (10~8 M).
The responses of portal vein preparations to BaCl 2 were obtained 1,2,3, and 5 days after adrenergic denervation (Fig. 6) . The sensitivity of the vessels to this agent gradually increased, reached a maximum between 2 and 3 days, and returned toward control levels by day 5. The point of maximum change represents a 1.4-fold increase in sensitivity. The time course of the EC50 values for both KG and ACh showed a tendency for the sensitivity to increase at days 2 and 3 and return to control levels by day 5, although these changes were not statistically significant.
RELAXATION AFTER ADRENERGIC DENERVATION
Another parameter measured was the time course of the relaxation of portal vein preparations. The observations were made under control conditions and after in vitro and in vivo denervation with 6-OHDA. The in vitro denervation of portal vein with 6-OHDA has been described previously. 20 -24 The procedure employed for these measurements deserves some comments: NE was allowed to act on the preparations for 2.5 minutes. The time integral of the tension developed over this period of time was evaluated and taken as 0% relaxation. After the 2.5minute exposure NE was washed out of the preparations; this required 15 seconds. After two consecutive washes (continuous supervision for 30 seconds), the tension developed again was measured for 2.5 minutes. After another waiting period of 30 seconds a final measurement of the time integral of the tension developed over a 2.5minute period was performed. Thus, two quantitations were made: one beginning 30 seconds and the other 3 minutes after washing the NE out of the muscle chambers. The return of spontaneous activity to control levels was slower in denervated than in control veins during the first 2.5 minutes after washing the NE. Three minutes after washing out the drug the spontaneous activity of the control veins had returned nearly to pre-NE levels, but that of the denervated veins still was much above pre-drug levels. Figure 7 presents data Obtained 3 minutes after washing the NE out of the preparations and expressed as percent of the contraction integrals obtained during exposure to the test NE concentration. The test concentrations of NE used for these experiments were those which elicited approximately the same responses (approximately 80% of maximum contraction) in the concentration-response curves (see Fig. 5 ). Three minutes after NE washout the contractile activity of the control veins was slightly above the values obtained before addition of NE to the preparations. A similar pattern of response was found after in vitro 6-OHDA treatment. On the other hand, 1, 2, and 3 days after in vivo treatment with 6-OHDA, the contractile activity of the veins always was higher than that of control and in vitro 6-OHDA-treated vessels. It always took longer for the contractile activity of the in vivo 6-OHDAtreated veins to return to baseline.
MICROELECTRODE MEASUREMENTS
The resting membrane potential (Em) of control and denervated portal vein preparations is shown in Figure 8 , which displays the time course of the changes in En, expressed as percent decrease. The denervated veins showed a gradual depolarization which reached a maximum 3 days after sympathectomy. The difference is decreased at day 5; this indicates a return of the E,,, toward control values.
Discussion
This series of experiments has shown that treatment of rats with 6-OHDA produces functional impairment of the adrenergic terminals and therefore in vivo denervation of portal veins. This denervation induced pharmacological ) . Asterisks as in Figure 2 . and electrophysiological changes in these blood vessels that may be regarded as having a postjunctional origin. The studies with 3 H-NE indicate that the neuronal uptake was markedly depressed 1 day after 6-OHDA treatment. One day after 6-OHDA injection no fluorescence could be observed in the specimens examined and no responses to nerve stimulation were obtained. Thus, the failure of the in vivo 6-OHDA treatment to cause a complete uptake inhibition at day 1 may indicate that 6-OHDA caused depletion of most terminals and functional impairment of some, but not all nerve terminals, which were still able to take up 3 H-NE. 3 H-NE uptake steadily increased at days 3 and 5, and this coincided with the restoration of the responses to field stimulation and the return of catecholamine fluorescence. Taken together, the results of the field stimulation experiments, :) H-NE uptake, and fluorescence histochemistry show that the nerve damage caused by the 6-OHDA treatment employed is reversible. In this context the term "reversible" is used to express the restoration (partial or total) of the mechanisms of NE storage, uptake, and release in the adrenergic nerve endings. Thus, a complete adrenergic denervation of the portal veins was not maintained throughout the 5-day period. This is of importance in relation to the interpretation of the time courses of the various parameters investigated because all of the alterations observed seem to return toward control levels at approximately 5 days after 6-OHDA treatment (see below).
The 3.5-fold increase in NE sensitivity observed after in vivo chemical denervation cannot be entirely accounted for on the basis of a loss of neuronal uptake. Previous results of Aprigliano and Hermsmeyer 20 showed that complete in vitro adrenergic denervation by 6-OHDA caused only a 1.6-fold increase in sensitivity to NE that was attributable to the loss of the uptake mechanism. Thus, it can be postulated that a postjunctional component (changes in the muscle cells) is implicated in the present results. The changes in NE sensitivity not only involve a decrease in EC 5( >, but also an increase in the responses to low NE concentrations, which are not explained by impairment of neuronal uptake (see Fig. 5 ). The supersensitivity to NE thus seems to be a combination of prejunctional and postjunctional components; the postjunctional component reaches a maximum 3 days after chemical denervation.
The time course of the postjunctional supersensitivity in portal veins is consistent with the time courses (between 1 and 3 days) found in other denervation experiments on the cardiovascular system. 25 " 27 However, in our experiments the maximum observed increase in sensitivity to NE occurred only for a period of approximately 1 day. A possible explanation for these findings is that, in order for the postjunctional changes to develop, the nerve influence has to be decreased to or below a "critical" level. The longer this influence is removed, the more pronounced will be the postjunctional alterations, up to a maximum value. However, because of reestablishment of functional innervation, the duration and perhaps the magnitude of the postjunctional supersensitivity to NE are limited, as in our experiments.
The supersensitivity of portal veins after adrenergic de-nervation also fits the criterion of relative nonspecificity 4 as indicated by the increase in sensitivity to BaCl 2 -The ECJO to BaCl 2 reached a minimum between 2 and 3 days and returned to control levels 5 days after denervation. These observations are consistent with the earlier proposition that a maintained increase in postjunctional supersensitivity is prevented by the reestablishment of the innervation approximately 3 days after denervation. In this regard, 6-OHDA can be used to study both denervation and reinnervation of the portal vein within a short period of time.
Perhaps no single mechanism is responsible for the changes observed after adrenergic denervation of the portal veins. As described in the Introduction, denervation may induce alterations in biochemistry, morphology, and excitability of the effector cells. One mechanism that could contribute to the increase in sensitivity to drugs is the decrease in En, detected after denervation. This excitability change has been observed after denervation of skeletal muscles, in the smooth muscle of the vas deferens, and in cardiac muscle,"" 15 and it has been shown for the first time in vascular smooth muscle in the present work. The agonists used in these experiments normally initiate their effects through a depolarization of the cell membrane. 28 -29 Thus, the displacement of the En, toward a less negative value could constitute a facilitatory effect for the initiation of the actions of these drugs. The maximum En, change observed was a depolarization of approximately 4 mV. This would represent a significant decrease, for the entire concentration-response curve may be obtained by a less than 30 raV change in Em . 29 The time course of Em shows a maximum decrease, which coincides with the maximum observed increases in sensitivity to NE and BaCl 2 , and a return toward control values. Thus, like the increase in drug sensitivity, the En, returns to normal as functional innervation is reestablished.
The electrophysiological data thus suggest that an alteration in excitability of the myovascular cells of the portal vein occurs after denervation. Many factors could be responsible for a change in the cell's excitability and Em. Denervation or the removal of NE from the cell's environment might alter ionic conductances (e.g., g K ), that result in a decrease in En,. Another possibility is that the neurotransmitter or the innervation could directly or indirectly affect the metabolic activity of the cell at the membrane or some other level. Denervation of skeletal 30 and smooth muscle of the vas deferens 6 has been reported to cause alterations in the metabolic activity of the effectors. Changes in the metabolic rate and energy supply of smooth muscle cells of the teniae coli can affect their electrical and mechanical activity as well. 31 The prolongation of the relaxation times of denervated veins after in vitro 6-OHDA probably could be explained by a decreased neuronal uptake which would tend to increase the time required for NE removal from the biophase. However, the significant increase in relaxation times observed 1,2, and 3 days after denervation is much higher than that observed after in vitro 6-OHDA and thus indicates additional alterations. For instance, denervation might alter permeability of the muscle membrane to ions that influence the relaxing system. Furthermore, the in-creased electrical excitability may have lengthened the period of time required for the pacemaker cells to return to their pre-drug activity, as indicated by higher frequency and amplitude of spontaneous contractions.
Finally, these experiments also show that supersensitivity can be obtained even though the denervation is not complete. The observation that partial denervation caused postjunctional supersensitivity is consistent with the law of denervation proposed by Cannon, Rosenblueth, and Garcia Ramos. 16 As to the nature of the trophic influence, these experiments do not provide a direct answer. All that could be observed was that removal of the nerve influence induced functional changes in the vascular muscle cells which could be due to the lack of appropriate transmitter release. However, the neurotransmitter may not be the only trophic factor involved. It is possible that another influence contained in, or released by, the nerve also is necessary. The studies by Chamley and Campbell 32 and Luco and Luco 33 suggest that an additional factor is involved in the trophic influence of the sympathetic nervous system.
In conclusion, these experiments have shown that postjunctional changes are present as early as 1 day after sympathetic denervation of portal veins with 6-OHDA. The data suggest that membrane depolarization and a slower rate of relaxation can be brought about by removal of a trophic influence of the sympathetic nervous system on the vascular smooth muscle cells.
